Cite
HARVARD Citation
Qin, S. et al. (2018). Efficacy and safety of first-line sunitinib in Chinese patients with metastatic renal cell carcinoma. Future oncology. pp. 1835-1845. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Qin, S. et al. (2018). Efficacy and safety of first-line sunitinib in Chinese patients with metastatic renal cell carcinoma. Future oncology. pp. 1835-1845. [Online].